Abstract
Allergic diseases emerge as a substantial health problem of the 21st century. Current therapies including combination therapies of corticosteroids and β2-agonists are highly effective, inexpensive and relatively safe. However, these medicaments only relieve symptoms but are not curing disease. So the challenge has to be to develop new therapeutics which are as effective as present medicaments without any side effects and hopefully even heal the disease. It has become clear over the past years that Th2-cells and their cytokines have an outstanding role in the development of airway hyperresponsiveness, airway inflammation, airway remodelling and reversible airway obstruction, the cardinal symptoms of allergic asthma. There is legitimate hope that down regulation of these factors could result in a susceptible damage of pathologic mechanisms. Out of different gene silencing techniques RNAi seems to be the most promising method to achieve long-lasting and effective abrogation of key elements in allergic diseases. In particular, this review will highlight the potential of small interfering RNAs to specifically inhibit the function of transcription factors and tyrosine kinases which are involved in orchestrating an allergic immune response.
Keywords: Allergy, asthma, siRNA, transcription factors
Current Molecular Medicine
Title: Targeting Allergic Airway Diseases by siRNA: An Option for the Future?
Volume: 9 Issue: 4
Author(s): Holger Meinicke, Yasemin Darcan and Eckard Hamelmann
Affiliation:
Keywords: Allergy, asthma, siRNA, transcription factors
Abstract: Allergic diseases emerge as a substantial health problem of the 21st century. Current therapies including combination therapies of corticosteroids and β2-agonists are highly effective, inexpensive and relatively safe. However, these medicaments only relieve symptoms but are not curing disease. So the challenge has to be to develop new therapeutics which are as effective as present medicaments without any side effects and hopefully even heal the disease. It has become clear over the past years that Th2-cells and their cytokines have an outstanding role in the development of airway hyperresponsiveness, airway inflammation, airway remodelling and reversible airway obstruction, the cardinal symptoms of allergic asthma. There is legitimate hope that down regulation of these factors could result in a susceptible damage of pathologic mechanisms. Out of different gene silencing techniques RNAi seems to be the most promising method to achieve long-lasting and effective abrogation of key elements in allergic diseases. In particular, this review will highlight the potential of small interfering RNAs to specifically inhibit the function of transcription factors and tyrosine kinases which are involved in orchestrating an allergic immune response.
Export Options
About this article
Cite this article as:
Meinicke Holger, Darcan Yasemin and Hamelmann Eckard, Targeting Allergic Airway Diseases by siRNA: An Option for the Future?, Current Molecular Medicine 2009; 9 (4) . https://dx.doi.org/10.2174/156652409788167041
DOI https://dx.doi.org/10.2174/156652409788167041 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Potential of Adipose-derived Stem Cells in the Treatment of
Pulmonary Diseases
Current Stem Cell Research & Therapy The Role of Minocycline in Ischemia-Reperfusion Injury: A Comprehensive Review of an Old Drug with New Implications
Recent Patents on Cardiovascular Drug Discovery DNA Methylation Markers in Lung Cancer
Current Genomics Natural Anti-inflammatory Compounds as Drug Candidates in Alzheimer’s Disease
Current Medicinal Chemistry A Review of Pharmacological Properties and Toxicological Effects of Adiantum capillus-veneris L.
Current Drug Discovery Technologies Classic Histamine H1 Receptor Antagonists: A Critical Review of their Metabolic and Pharmacokinetic Fate from a Birds Eye View
Current Drug Metabolism Patent Annotations
Recent Patents on Inflammation & Allergy Drug Discovery Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation
Current Medicinal Chemistry Gender Differences in Metabolic Syndrome – A Key Research Issue
Endocrine, Metabolic & Immune Disorders - Drug Targets Chronic Inflammatory Diseases and the Acute Respiratory Distress Syndrome (ARDS)
Current Pharmaceutical Design Cereal Exposures in the Infant Diet and Risk of Diabetes Autoimmunity in Children
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Current Clinical Pharmacology Lysine-derived Alkaloids: Overview and Update on Biosynthesis and Medicinal Applications with Emphasis on Quinolizidine Alkaloids
Mini-Reviews in Medicinal Chemistry Therapeutic Use of Chemokines
Current Pharmaceutical Design Prevalence and Factors Associated With Low Aerobic Performance Levels in Adolescents: A Systematic Review
Current Pediatric Reviews Protein Phosphatase Inhibition: Structure Based Design. Towards New Therapeutic Agents
Current Pharmaceutical Design Anti-Respiratory Syncytial Virus Mechanism of <i>Houttuynia cordata</i> Thunb Exploration based on Network Pharmacology
Combinatorial Chemistry & High Throughput Screening Vitamin D in COPD - A Pleiotropic Micronutrient in a Multisystem Disease
Current Respiratory Medicine Reviews Acute Respiratory Failure in Obstetric Patients
Current Women`s Health Reviews